Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 191

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study

Open access
Chew, Emily Y., Clemons, Traci E., Bressler, Susan B., Elman, Michael J., Danis, Ronald P., Domalpally, Amitha, Heier, Jeffrey S., Kim, Judy E., Garfinkel, Richard · 2014 · Ophthalmology

Abstract

Objective To determine whether home monitoring with ForeseeHome device, using macular visual field testing with hyperacuity techniques and tele-monitoring, results in earlier detection of age-related macular degeneration associated choroidal neovascularization (CNV), reflected in better visual acuity, when compared with standard care. The main predictor of treatment benefit from anti-vascular endothelial growth factor (VEGF) agents is the visual acuity at the time of CNV treatment. Design Unmasked, controlled, randomized clinical trial. Participants 1970 participants, aged 53 to 90 years, at high risk of developing CNV were screened; 1520, mean age 72.5 years enrolled in the HOme Monitoring of the Eye (HOME) Study in 44 Age-Related Eye Disease Study2) clinical centers. Interventions 1) Standard care arm: investigator-specific instructions were provided for self-monitoring vision at home followed by report of new symptoms to clinic. 2) Standard Care and Device arm: device provided with recommendation for daily testing. The device monitoring center received test results and reported changes to the clinical centers who contacted participants for examination. Main Outcome Measures The difference in best-corrected visual acuity scores between baseline and detection of CNV. The event was determined by investigators based on clinical exam, color fundus photographs, fluorescein angiography, and optical coherence tomography. Masked graders at central reading center evaluated the images using standardized protocols. Results 763 participants were randomized to device monitoring and 757 to standard care, and followed for a mean of 1.4 years between July 2010-December 2013. At the pre-specified interim analysis, 82 participants progressed to CNV, 51 in the device arm and 31 in the standard care arm. The primary analysis achieved statistical significance with the participants in the device arm demonstrating a smaller decline in visual acuity with fewer letters lost from baseline to CNV detection (median (interquartile range [IQR]):−4 [−11.0, −1.0] letters) compared with standard care (median [IQR]:−9 [−14.0, −4.0] letters) (p=0.021), resulting in better visual acuity at CNV detection in the device arm. The Data and Safety Monitoring Committee recommended early study termination for efficacy. Conclusions Persons at high risk for developing CNV benefit from the home monitoring strategy for earlier detection of CNV development which increases the likelihood of better visual acuity results following intravitreal anti-VEGF therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ophtha.2013.10.027

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 191

Metadata

Authors
Chew, E. Y., Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., & Garfinkel, R.
Venue
Ophthalmology
Publisher
Elsevier BV
Published
2014-02
Volume
121
Issue
2
Pages
535-544
ISSN
0161-6420 (ISSN-L)
OpenAlex
W2041388318
Cited by
191
References
7
FWCI
11.75
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study. https://app.cochat.ai/papers/10.1016/j.ophtha.2013.10.027
The paper
Chew, E. Y., Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., & Garfinkel, R. (2014). Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study. Ophthalmology. https://doi.org/10.1016/j.ophtha.2013.10.027

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.